Xenon Pharmaceuticals Inc. – Product Pipeline Review
– Q2 2011
Reference Code: GMDHC1297CDB
Publication Date: JULY 2011
Xenon Pharmaceuticals Inc. – Product Pipeline Review – Q2 2011 GMDHC1297CDB / Published JULY 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied Page(1)
Xenon Pharmaceuticals Inc. – Product Pipeline Review
Ta b le o f Co n te n ts
Table of Contents 2
List of Tables 4
List of Figures 4
Xenon Pharmaceuticals Inc. Snapshot 5
Xenon Pharmaceuticals Inc. Overview 5
Key Information 5
Key Facts 5
Xenon Pharmaceuticals Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Xenon Pharmaceuticals Inc. – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Xenon Pharmaceuticals Inc. – Pipeline Products Glance 11
Xenon Pharmaceuticals Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Xenon Pharmaceuticals Inc.–Early Stage Pipeline Products 13
Pre-Clinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Xenon Pharmaceuticals Inc. – Drug Profiles 15
Topical XEN402 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
XPF-001 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Oral XEN402 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
XEN403 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Stearoyl-CoA Desaturase-1 Drug Development Program 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
XEN 401 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
XEN 501 21
Product Description 21
Xenon Pharmaceuticals Inc. – Product Pipeline Review – Q2 2011 GMDHC1297CDB / Published JULY 2011
©Global Markets Direct.. This report is a licensed product and is not to be photocopied Page(2)
Xenon Pharmaceuticals Inc. – Product Pipeline Review
Mechanism of Action 21
R&D Progress 21
Cardiovascular Program 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Drug For Anemia Of Inflammation 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Iron Overload Program 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Xenon Pharmaceuticals Inc. – Pipeline Analysis 25
Xenon Pharmaceuticals Inc. – Pipeline Products by Therapeutic Class 25
Xenon Pharmaceuticals Inc. - Pipeline Products By Target 26
Xenon Pharmaceuticals Inc. – Pipeline Products by Route of Administration 27
Xenon Pharmaceuticals Inc. – Pipeline Products by Molecule Type 28
Xenon Pharmaceuticals Inc. – Recent Pipeline Updates 29
Xenon Pharmaceuticals Inc. - Dormant Projects 30
Xenon Pharmaceuticals Inc. – Locations And Subsidiaries